- Home
- LSF vs CCM Comparison
LSF vs CCM Comparison
Compare LSF & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSF | CCM |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Nursing Services |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.8M | 23.8M |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | LSF | CCM |
|---|---|---|
| Price | $3.34 | $4.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 124.1K | 11.8K |
| Earning Date | 02-25-2026 | 09-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $48,146,862.00 | ★ $51,056,841.00 |
| Revenue This Year | $18.05 | N/A |
| Revenue Next Year | $17.53 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.73 | N/A |
| 52 Week Low | $1.98 | $3.54 |
| 52 Week High | $8.26 | $10.77 |
Technical Indicators
Market Signals| Indicator | LSF | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 61.78 | 47.20 |
| Support Level | $3.07 | $4.13 |
| Resistance Level | $3.62 | $5.40 |
| Average True Range (ATR) | 0.33 | 0.62 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 73.88 | 25.63 |
Price Performance
Historical ComparisonAbout LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.